DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

Galena Biopharma, Inc. (NASDAQ: GALE)

1.83 -0.01 (-0.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GALE $1.83 -0.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.85
Previous Close $1.84
Daily Range $1.80 - $1.86
52-Week Range $1.43 - $4.24
Market Cap $222.3M
P/E Ratio -2.42
Dividend (Yield) $0.00 (0.0%)
Volume 890,949
Average Daily Volume 1,460,711
Current FY EPS -$0.36

Sector

Healthcare

Industry

Drug Makers

Galena Biopharma, Inc. (GALE) Description

Galena Biopharma Inc is a biotechnology company focused on discovering developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. Website: http://www.galenabiopharma.com/

News & Commentary Rss Feed

Fantastic News: A Revolutionary New Breast Cancer Drug Is on the Way

For the first time in more than 10 years a revolutionary new breast cancer treatment is ready to hit pharmacy shelves targeted at the most common type of breast cancer.

Announcing This Week's Performance Award Winners - Joe Springer And Matt Gravitt

In Case You Missed It, Breast Cancer Detection Just Took a Gigantic Leap Forward

When battling breast cancer, time is of the essence. That's why the discovery of this new breast cancer detection technique really is that big of a deal.

Advaxis: Heavily Promoted And Misleading Investors

Galena Biopharma (GALE) Is Weak On High Volume Today

Galena Biopharma (GALE) Jumps: Stock Rises 9.1% - Tale of the Tape

Galena Biopharma (GALE) Jumps: Stock Rises 9.1% - Tale of the Tape

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ...

Galena: I Am Bullish, However, Nobody Has Paid Me For My Stance

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th A

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th American Society of

See More GALE News...

GALE's Top Competitors

GALE $1.83 (-0.54%)
Current stock: GALE
AMGN $158.97 (0.56%)
Current stock: AMGN
GILD $104.19 (-0.23%)
Current stock: GILD
BIIB $410.10 (0.28%)
Current stock: BIIB